LIN, Ann
$150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
États-Unis
A novel pharmacological strategy to boost innate immunity and provide broad-spectrum antimicrobial activity through hypoxia-inducible factor-1 (HIF-1)